Florian Föger, PhD

Florian Föger is the founder and CEO of Cyprumed GmbH. Cyprumed is a dedicated oral drug delivery company with strong focus on the oral delivery of therapeutic peptide drugs (eg. Macrocyclic peptides, GLP-1 peptides) Florian is also one of the inventors of its oral peptide drug delivery technology. Previously, Florian Föger had different positions at Novo Nordisk amongst others Director of Oral Formulation Research. He is the inventor of more than 10 patent applications in the field of oral peptide delivery and author of 20 peer reviewed research articles in the oral delivery field. Florian Föger received a PhD in Pharmaceutical Sciences from the University of Innsbruck, Austria.